Pegasus Asset Management, Inc. Sorrento Therapeutics, Inc. Transaction History

Pegasus Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 13, 2020	SELL	$6.17 - $18.82 $92,550 - $282,300	-15,000 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$1.45 - $4.17 $21,750 - $62,550	15,000 New	15,000 $51,000
Q1 2018 May 01, 2018	SELL	$4.5 - $9.95 $67,500 - $149,250	-15,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$1.75 - $3.8 $26,250 - $57,000	15,000	15,000 $57,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Pegasus Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Pegasus Asset Management, Inc. with notifications on news.